Quick answer: Ethical marketing of the CMAT Advantage™ system means leading with clinical evidence, transparent reimbursement data, and patient-centered education rather than fear-based messaging or unsubstantiated claims. Practices that prioritize education over sales consistently report higher patient acceptance rates and stronger long-term compliance.
Why Does Ethical Marketing Matter for Diagnostic Testing Services?
Medical practices adding the CMAT Advantage™ system face a unique marketing challenge: communicating the value of preventive vascular and autonomic testing to patients who may never have heard of ABI, HRV, or sudomotor function assessments. According to the American Medical Association, patient trust directly correlates with how transparently a practice communicates about diagnostic services and their costs. Practices that lead with clinical evidence — such as the fact that Peripheral Arterial Disease affects approximately 8.5 million Americans over age 40, according to the CDC — build credibility that translates into sustainable patient volume.
The CMAT Advantage™ system measures multiple vascular and autonomic biomarkers in a single 7–10 minute, non-invasive session. This clinical efficiency is a genuine differentiator worth communicating — but the messaging must remain factual and compliant with FDA regulations for 510(k)-cleared devices.
What Are the Compliance Boundaries for Marketing FDA-Cleared Diagnostic Devices?
The FDA distinguishes between “FDA-cleared” (510(k) pathway) and “FDA-approved” (PMA pathway). The CMAT Advantage™ system is FDA-cleared, not FDA-approved — and this distinction matters in all marketing materials. Using “FDA-approved” for a 510(k) device is a compliance violation that can trigger regulatory action.
Key compliance guidelines for CMAT Advantage marketing include: using only cleared indications in promotional materials, avoiding off-label claims about disease diagnosis or treatment, including appropriate disclaimers on reimbursement projections (CPT codes 93922, 93923, 95921, and 95923 are covered but reimbursement varies by payer and region), and ensuring all patient-facing materials accurately represent what the test measures versus what it diagnoses.
How Should Practices Educate Patients About CMAT Advantage Testing?
Effective patient education for the CMAT Advantage™ system focuses on three elements: what the test measures, why early detection matters, and what the patient experience involves. A well-designed patient education workflow typically includes a brief educational brochure in the waiting room, a 2–3 minute verbal explanation during the appointment, and a follow-up summary of results with clear next-step recommendations.
The most effective educational messaging emphasizes that the CMAT Advantage test is non-invasive (no needles, no fasting required), takes only 7–10 minutes, is covered by Medicare and most commercial insurance plans, and provides objective data to support evaluation of vascular and autonomic dysfunction in at-risk patients. Practices using this evidence-based education approach report patient acceptance rates of 70–85% when the test is recommended by their physician.
What Marketing Channels Work Best for Preventive Diagnostic Services?
For independent practices marketing CMAT Advantage testing, the most effective channels are internal referrals from existing patients, educational content on the practice website, and targeted outreach to at-risk patient populations already in the practice’s EHR — particularly diabetic patients, patients over 50, and those with cardiovascular risk factors. External advertising should focus on educational messaging rather than promotional offers, and all digital marketing must comply with HIPAA requirements for patient communication. Practices that want a structured approach to patient-privacy rules often engage a HIPAA compliance consulting partner to align their privacy, security, and breach-response policies before scaling outreach.
How Can Practices Avoid Common Marketing Pitfalls With Diagnostic Devices?
The most common marketing mistakes with diagnostic testing services include: overstating reimbursement revenue without accounting for payer mix variation, using patient testimonials that imply diagnostic certainty, and failing to include CPT code disclaimers on reimbursement-related content. Every piece of marketing material should be reviewed for accuracy by someone familiar with both the device’s cleared indications and applicable state and federal advertising regulations.
HealthWright Technologies provides compliant marketing templates, patient education materials, and billing guidance as part of the CMAT Advantage partnership program. Our implementation team helps practices develop ethical, effective marketing strategies that build patient trust while maximizing clinical adoption.
Frequently Asked Questions
Can I call the CMAT Advantage system FDA-approved in my marketing? No. The CMAT Advantage system is FDA-cleared through the 510(k) pathway, not FDA-approved. Always use “FDA-cleared” in all marketing materials.
What patient acceptance rate can I expect? Practices using evidence-based education typically see 70–85% acceptance when the physician recommends the test.
Do I need disclaimers on CPT code information? Yes. All reimbursement content should note that CPT codes are informational only and do not guarantee reimbursement.
What marketing materials does HealthWright provide? Compliant patient education brochures, website templates, and billing guidance are included in the CMAT Advantage partnership.
Can I use patient testimonials? Yes, with appropriate HIPAA consent and disclaimers that testimonials do not imply diagnostic certainty or guaranteed outcomes.
Ready to market CMAT Advantage testing ethically and effectively? Contact HealthWright Technologies at (678) 322-7146 or email contact@healthwrighttechnologies.com for compliant marketing support and partnership information.
Disclaimer: CPT codes referenced in this article (93922, 93923, 95921, 95923) are provided for informational purposes only and do not guarantee reimbursement. Verify code applicability and coverage with each payer. Marketing guidance in this article is general in nature and does not constitute legal advice.
Ready to see the CMAT Advantage in your practice?
Book a free 15-minute demo — see the full PAD + autonomic workup and triple-CPT billing potential, with no obligation. Backed by our 90-day buyback guarantee.
Book a Free Demo →
